---
title: "Privia Health Group (PRVA) Gets a Buy from Citi"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295448514.md"
description: "Citi analyst Daniel Grosslight reiterated a Buy rating on Privia Health Group (PRVA) with a $35.00 price target. This aligns with the stock's Strong Buy consensus and an average price target of $31.25."
datetime: "2026-08-10T20:35:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295448514.md)
  - [en](https://longbridge.com/en/news/295448514.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295448514.md)
generator: "portal-rs"
---

# Privia Health Group (PRVA) Gets a Buy from Citi

In a report released today, Daniel Grosslight from Citi reiterated a Buy rating on Privia Health Group, with a price target of $35.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Grosslight covers the Healthcare sector, focusing on stocks such as GoodRx Holdings, Agilon Health, and Evolent Health. According to TipRanks, Grosslight has an average return of 4.1% and a 47.77% success rate on recommended stocks. 

Privia Health Group has an analyst consensus of Strong Buy, with a price target consensus of $31.25.

### Related Stocks

- [PRVA.US](https://longbridge.com/en/quote/PRVA.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [GDRX.US](https://longbridge.com/en/quote/GDRX.US.md)
- [AGL.US](https://longbridge.com/en/quote/AGL.US.md)
- [EVH.US](https://longbridge.com/en/quote/EVH.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [Barclays Reaffirms Their Hold Rating on Privia Health Group (PRVA)](https://longbridge.com/en/news/297307735.md)
- [Privia Health files Form 3 for director Ernest Opella Finley](https://longbridge.com/en/news/297952652.md)
- [AcuCort notifies availability of August 2026 newsletter press release](https://longbridge.com/en/news/297505730.md)
- [Morgan Stanley Remains a Buy on Rockwell Automation (ROK)](https://longbridge.com/en/news/297785354.md)
- [Celsius: Buy Rating Reaffirmed as Energy Portfolio Strengthens; Price Target Maintained at $42](https://longbridge.com/en/news/297780521.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**